Annual Outcomes with Transcatheter Valve Therapy from the STS/ACC TVT Registry

Journal of the American College of Cardiology

Volumn 66, Issue 25, 2015, Pages 2813-2823

  Holmes, David R ^a   Nishimura, Rick A ^a   Grover, Frederick L ^b   Brindis, Ralph G ^c   Carroll, John D ^b   Edwards, Fred H ^d   Peterson, Eric D ^e   Rumsfeld, John S ^f   Shahian, David M ^g   Thourani, Vinod H ^h   Tuzcu, E Murat ⁱ   Vemulapalli, Sreekanth ^e   Hewitt, Kathleen ^j   Michaels, Joan ^j   Fitzgerald, Susan ^j   Mack, Michael J ^k  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^k SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

more..

Author keywords

aortic stenosis; aortic valve replacement; transcatheter aortic valve replacement; valvular heart disease; VARC

Indexed keywords

AGED; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FRAIL ELDERLY; HEALTH CARE DELIVERY; HEALTH STATUS; HUMAN; IMPLANT REGISTRY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; SEDATION; SELF REPORT; TOTAL QUALITY MANAGEMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; VALVULAR HEART DISEASE; VASCULAR ACCESS; VASCULAR DISEASE; AORTIC VALVE STENOSIS; CLINICAL TRIAL; EPIDEMIOLOGY; FOLLOW UP; HOSPITAL MORTALITY; MULTICENTER STUDY; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; PATIENT SELECTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 84955747700     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.021     Document Type: Article

References (22)

1. J.D. Carroll, F.H. Edwards, D. Marinac-Dabic, and et al. The STS-ACC Transcatheter Valve Therapy National Registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies J Am Coll Cardiol 62 2013 1026 1034
2. J.S. Rumsfeld, D.R. Holmes Jr., W.G. Stough, and et al. Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry J Am Coll Cardiol Intv 8 2015 377 381
3. J.D. Carroll, J. Shuren, T.S. Jensen, and et al. Transcatheter valve therapy registry is a model for medical device innovation and surveillance Health Aff (Millwood) 34 2015 328 334
4. M.J. Mack, and D.R. Holmes Jr. Rational dispersion for the introduction of transcatheter valve therapy JAMA 306 2011 2149 2150
5. A. Sedrakyan, D. Marinac-Dabic, and D.R. Holmes The international registry infrastructure for cardiovascular device evaluation and surveillance JAMA 310 2013 257 259
6. Center for Devices and Radiological Health, U.S. Food and Drug Administration. Strengthening our national system for medical device postmarket surveillance: update and next steps. 2013. Available at: http://www.fda.gov/downloads/MedicalDevices/Safety/CDRHPostmarketSurveillance/UCM348845.pdf. Accessed October 15, 2015.
7. M.J. Mack, J.M. Brennan, R.G. Brindis, et al. for the STS/ACC TVT Registry Outcomes following transcatheter aortic valve replacement in the United States JAMA 310 2013 2069 2077
8. J.M. Brennan, D.R. Holmes, M.W. Sherwood, and et al. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States Ann Thorac Surg 98 2014 2016 2022 discussion 2022
9. D.R. Holmes Jr., M. Brennan, J.S. Rumsfeld, et al. for the STS/ACC TVT Registry Clinical outcomes at 1 year following transcatheter aortic valve replacement JAMA 313 2015 1019 1028
10. M.B. Leon, N. Piazza, E. Nikolsky, and et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
11. A.P. Kappetein, S.J. Head, P. Généreux, and et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
12. C.P. Green, C.B. Porter, D.R. Bresnahan, and et al. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure J Am Coll Cardiol 35 2000 1245 1255
13. S.V. Arnold, J.A. Spertus, Y. Lei, and et al. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis Circ Heart Fail 6 2013 61 67
14. T.M. Dewey, D. Brown, W.H. Ryan, and et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement J Thorac Cardiovasc Surg 135 2008 180 187
15. M. Barbanti, R.K. Binder, M. Freeman, and et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement EuroIntervention 9 2013 929 935
16. N.M. Van Mieghem, P. Généreux, R.M. van der Boon, and et al. Transcatheter aortic valve replacement and vascular complications definitions EuroIntervention 9 2014 1317 1322
17. G. Latsios, U. Gerckens, L. Buellesfeld, and et al. "Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI Catheter Cardiovasc Interv 76 2010 431 439
18. D. Tchetche, T. Modine, B. Farah, and et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve Accutrak system EuroIntervention 8 2012 556 562
19. R.M. van der Boon, N.M. Van Mieghem, D.A. Theuns, and et al. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic Core Valve system Int J Cardiol 168 2013 1269 1273
20. S. Bleiziffer, H. Ruge, J. Hörer, and et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation J Am Coll Cardiol Intv 3 2010 524 530
21. R.A. Nishimura, C.M. Otto, R.O. Bonow, and et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2438 2488
22. Husten L. Using registry data, FDA expands indication for Edwards' Sapien Transcatheter Heart Valves. Forbes. September 23, 2013. Available at: http://www.forbes.com/sites/larryhusten/2013/09/23/using-registry-data-fda-expands-indication-for-edwards-sapien-transcatheter-heart-valves/. Accessed October 15, 2015.